Cell therapy for relapsed cancer patients | Video
02:57 Min
Singapore has successfully treated its first patient using what is known as chimeric antigen receptor T-cell, or CAR-T therapy. But as Cheryl Goh reports, the treatment comes with a hefty price tag.
12 Sep 2021 11:10pm
Singapore has successfully treated its first patient using what is known as chimeric antigen receptor T-cell, or CAR-T therapy. But as Cheryl Goh reports, the treatment comes with a hefty price tag.
Popular Shows
